SILO PHARMA, INC. Loans Payable, Current
SILO PHARMA, INC. (SILO) had Loans Payable, Current of $660.28 thousand as of 2023-03-31, per its 10-Q filed 2023-05-12.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Notes and Loans Payable, Current
us-gaap:LoansPayableCurrent · last filed 2023-05-12
- 2023-03-31: Loans Payable, Current $660.28K.
- 2022-12-31: Loans Payable, Current $364.22K.
- 2022-09-30: Loans Payable, Current $16.45K.
- 2022-06-30: Loans Payable, Current $40.82K.
| Period end | Loans Payable, Current |
|---|---|
| 2023-03-31 | $660.28K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $364.22K 10-Q · filed 2023-05-12 |
| 2022-09-30 | $16.45K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $40.82K 10-Q · filed 2022-08-01 |
| 2022-03-31 | $64.84K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $417.94K 10-K · filed 2023-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |